Guiding future bladder cancer treatment with spatial proteomics
Did you
know that bladder cancer is the ninth most common type of cancer? Researchers
at SciLifeLab are working to support more informed clinical decision-making and enable a more precise and individualized cancer care.
By combining advanced molecular analysis with clinical expertise, the work is an example of SciLifeLab’s efforts in translating technology development into healthcare applications.
Shedding light on receptor selectivity: "one of the most comprehensive projects in my entire scientific career"
How do receptors tell apart signaling molecules that look almost identical, like adrenaline and dopamine? Researchers at SciLifeLab and Uppsala University have mapped how this selectivity works at the molecular level. The findings point to new ways of designing receptors with defined functions, with potential uses in drug development, biosensors, and gene therapy.
New vaccine strategy triggers antibodies capable of blocking diverse HIV variants
A recent study published in Nature presents a new vaccination strategy that can trigger antibodies capable of blocking many different HIV variants.
“For the first time since HIV vaccine candidates began to be evaluated in the 1990s, we see robust vaccine-elicited responses” says Gunilla Karlsson Hedestam, researcher at SciLifeLab.
SciLifeLab is expanding. Through a lease agreement that KTH has signed with Akademiska Hus, the floor space at Campus Solna will increase by 50 percent, supporting the goal to strengthen SciLifeLab’s world-leading research environment.
“The completion of this agreement is a milestone
for the development of SciLifeLab, and we now look forward to bringing the
entire project to fruition,” says Anders Söderholm, President of KTH.
Hong Kong–Sweden Innovation and Technology Collaboration
Hong-Kong’s Secretary for Innovation, Technology and Industry, Professor Sun Dong, visited Stockholm to further deepen exchange and collaboration between Hong Kong and Sweden in innovation and technology, and to gain a deeper understanding of Sweden’s experience and achievements in a high degree of integration of education, technology and industry.
Professor Sung Dong visited the renowned SciLifeLab, a national life science laboratory to advance molecular biosciences. The laboratory has fostered numerous Nobel Prize-winning research and development achievements.
You are by consent a subscriber to this newsletter. Your stored personal information is available to the SciLifeLab Operations Office staff for this purpose only.
You can revoke your consent at any time by clicking the Unsubscribe button, and we will promptly delete all of your stored personal information.
The personal information will also be deleted if the newsletter is no longer distributed.
